摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-(5-hydroxy-3,3-pentamethylenepent-1-yl)piperidine | 161884-94-2

中文名称
——
中文别名
——
英文名称
4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-(5-hydroxy-3,3-pentamethylenepent-1-yl)piperidine
英文别名
2-[1-[2-[4-(6-Fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]cyclohexyl]ethanol
4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-(5-hydroxy-3,3-pentamethylenepent-1-yl)piperidine化学式
CAS
161884-94-2
化学式
C22H31FN2O2
mdl
——
分子量
374.499
InChiKey
AGFDGRXPFNWACM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5
  • 重原子数:
    27
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.68
  • 拓扑面积:
    49.5
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    3,4,5-三甲氧基异氰酸苯酯4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-(5-hydroxy-3,3-pentamethylenepent-1-yl)piperidine 以23%的产率得到4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-[5-(3,4,5-trimethoxyphenyl-carbamoyloxy)-3,3-pentamethylenepent-1-yl]piperidine
    参考文献:
    名称:
    Mesolimbic selective antipsychotic arylcarbamates
    摘要:
    4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidine has been linked to various arylcarbamates to obtain compounds having affinity for dopamine-D-1 and -D-2, serotonin 5HT(2A) and alpha(1)-adrenoceptors. When Linkers with restricted flexibility are used, the biological activity is reduced indicating that a bended conformation is needed in this series of bioactive molecules. Compounds with a relatively low D-2/5HT(2A) affinity ratio in receptor binding experiments and high affinity for the alpha(1)-adrenoceptors exhibit a pharmacological profile which suggests a preferential effect on the mesocorticolimbic dopaminergic system and an 'atypical' antipsychotic activity. (C) Elsevier, Paris.
    DOI:
    10.1016/s0223-5234(99)80009-9
  • 作为产物:
    参考文献:
    名称:
    Mesolimbic selective antipsychotic arylcarbamates
    摘要:
    4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidine has been linked to various arylcarbamates to obtain compounds having affinity for dopamine-D-1 and -D-2, serotonin 5HT(2A) and alpha(1)-adrenoceptors. When Linkers with restricted flexibility are used, the biological activity is reduced indicating that a bended conformation is needed in this series of bioactive molecules. Compounds with a relatively low D-2/5HT(2A) affinity ratio in receptor binding experiments and high affinity for the alpha(1)-adrenoceptors exhibit a pharmacological profile which suggests a preferential effect on the mesocorticolimbic dopaminergic system and an 'atypical' antipsychotic activity. (C) Elsevier, Paris.
    DOI:
    10.1016/s0223-5234(99)80009-9
点击查看最新优质反应信息

文献信息

  • [EN] PIPERIDINE DERIVATIVES, THEIR PREPARATION AND USE<br/>[FR] DERIVES DE PIPERIDINE, LEUR PREPARATION ET LEUR UTILISATION
    申请人:NOVO NORDISK A/S
    公开号:WO1994027992A1
    公开(公告)日:1994-12-08
    (EN) Piperidine derivatives of formula (I) wherein n and m independently are 0, 1, 2, or 3; A is cycloalkylene or cycloalkylidenes; X is O or NH; Y is O, S, NH, NCN, or N-lower alkyl; R1 is 1,2-benzisoxazol-3-yl, 1H-indazol-3-yl, or 1-methyl-1H-indazol-3-yl, all of which may be substituted; R2 is H or alkyl; and R3 is phenyl optionally substituted, or R3 is (a) wherein Z together with the double bond in the phenyl ring represents a 5- or 6-membered heterocyclic ring; or R2 and R3 together with the nitrogen atom form a fused heterocyclic ring system; or pharmaceutically acceptable salts thereof are useful in the treatment of indications related to the CNS-system, cardiovascular system or to gastrointestinal disorders.(FR) L'invention concerne des dérivés de pipéridine selon la formule (I) dans laquelle n et m valent indépendamment 0, 1, 2 ou 3; A représente cycloalkylène ou cycloalkylidènes; X représente O ou NH; Y représente O, S, NH, NCN ou N-alkyle inférieur; R1 représente 1,2-benzisoxazol-3-yle, 1H-indazol-3-yle ou 1-méthyle-1H-indazol-3-yle, pouvant tous être substitués; R2 représente H ou alkyle; et R3 représente phényle optionnellement substitué, ou R3 représente (a) où Z, conjointement avec la double liaison dans la chaîne fermée phényle, représente une chaîne fermée hétérocyclique à 5 ou 6 éléments; ou R2 et R3, conjointement avec l'atome d'azote, forment un système de chaîne fermée hétérocyclique condensé. L'invention décrit également les sels pharmaceutiquement acceptables de ces dérivés. Ces dérivés et leurs sels sont utiles dans le traitement d'affections concernant le système nerveux central, le système cardio-vasculaire et les maladies gastro-intestinales.
  • Mesolimbic selective antipsychotic arylcarbamates
    作者:John Bondo Hansen、Anders Fink-Jensen、Birgitte V. Christensen、Frederick C. Grønvald、Lone Jeppesen、John P. Mogensen、Erik B. Nielsen、Mark A. Scheideler、Francis J. White、Xu-Feng Zhang
    DOI:10.1016/s0223-5234(99)80009-9
    日期:1998.11
    4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidine has been linked to various arylcarbamates to obtain compounds having affinity for dopamine-D-1 and -D-2, serotonin 5HT(2A) and alpha(1)-adrenoceptors. When Linkers with restricted flexibility are used, the biological activity is reduced indicating that a bended conformation is needed in this series of bioactive molecules. Compounds with a relatively low D-2/5HT(2A) affinity ratio in receptor binding experiments and high affinity for the alpha(1)-adrenoceptors exhibit a pharmacological profile which suggests a preferential effect on the mesocorticolimbic dopaminergic system and an 'atypical' antipsychotic activity. (C) Elsevier, Paris.
查看更多

同类化合物

苯并异恶唑Hsp90抑制剂 苯并[d]异噁唑-7-醇 苯并[d]异噁唑-5-胺 苯并[d]异噁唑-5-磺酰氯 苯并[D]异恶唑-3-甲酸 苯[D]异恶唑-3-醇 羟基伊洛哌酮 甲基6-氨基-1,2-苯并恶唑-3-羧酸酯 环己酮,2,3-二甲基-6-(1-甲基乙基)-,[2R-(2α,3ba,6ba)]-(9CI) 帕潘立酮杂质1 奈氟齐特 四氢-4-[[[4-[[[4-[[(3R)-四氢-3-呋喃基]氧基]-1,2-苯并恶唑-3-基]氧基]甲基]-1-哌啶基]甲基]-2H-吡喃-4-醇 唑尼酰胺-d4 唑尼沙胺钠 唑尼沙胺13C2-15N 唑尼沙胺 呋喃并[3,4:3,4]环丁二烯并[1,2:3,4]环丁二烯并[1,2-d]异噻唑(9CI) 呋喃并[3,4-f][1,2]苯并恶唑 呋喃并[3,4-e][1,2]苯并恶唑 呋喃并[3,2-g][1,2]苯并恶唑 呋喃并[3,2-f]-1,2-苯并异恶唑 呋喃并[2,3-f][1,2]苯并恶唑 呋喃并[2,3-e][1,2]苯并恶唑 叔-丁基(6-溴苯并[D]异噻唑-3-基)氨基甲酯 化合物 T29498 佐尼氯唑 伊潘立酮(R)-羟基杂质 alpha-甲基-3-苯基-1,2-苯并异恶唑-7-乙酸 [1,2]恶唑并[5,4-f][1,2]苯并恶唑 [1,2]恶唑并[5,4-e][2,1,3]苯并恶二唑 [1,1'-联苯基]-3-醇,2'-(5-乙基-3,4-二苯基-1H-吡唑-1-基)- [(3-氨基-1,2-苯并异恶唑-5-基)甲基]氨基甲酸叔丁酯 N,N-二甲基唑尼沙胺杂质 N-甲氧基-N-甲基苯并[d]异恶唑-3-甲酰胺 N-甲基唑尼沙胺 N-乙基苯异恶唑酮四氟硼酸盐 N-[(1,2-苯并恶唑-3-基甲基)磺酰基]乙酰胺 N-(苯并[D]异恶唑-3-基氧基-二甲基氨基-磷酰)-N-甲基-甲胺 N-(6-己酸)唑尼沙胺 7-硝基-1,2-苯并恶唑 7-甲氧基-3-甲基-1,2-苯并恶唑 7-甲基苯并[d]异恶唑-3-醇 7-溴苯并[d]异噁唑 7-溴苯并[D]异恶唑-3(2H)-酮 7-溴-3-氯苯并[D]异恶唑 7-溴-1,2-苯并恶唑-3-胺 7-氯-苯并[d]异恶唑 7-氟苯并[d]异噁唑-3-胺 7-氟-苯并[d]异噁唑-3-醇 6-苯基苯并[d]异噁唑-3-胺